Celano Christopher M, Freudenreich Oliver, Fernandez-Robles Carlos, Stern Theodore A, Caro Mario A, Huffman Jeff C
Harvard Medical School, Boston, Massachusetts, USA.
Dialogues Clin Neurosci. 2011;13(1):109-25. doi: 10.31887/DCNS.2011.13.1/ccelano.
The literature is filled with reports that link medications with the onset or progression of depression. Because depression is so common in patients with medical illness, assessing whether a medication has in fact caused depression, or whether the relationship is coincidental, can be challenging. In this article, we review the literature on the association between medications and depression. For most agents, there are case reports or small studies linking the medication with the onset of depression, but more rigorous prospective studies are either lacking or found no association between the agent and depression. However, several medications, (eg, barbiturates, vigabatrin, topiramate, flunarizine, corticosteroids, mefloquine, efavirenz, and interferon-alpha) do appear to cause depression in some patients and should be used with caution in patients at risk for depression.
文献中充斥着将药物与抑郁症的发作或进展联系起来的报告。由于抑郁症在患有内科疾病的患者中非常常见,因此评估一种药物是否真的导致了抑郁症,或者这种关系是否只是巧合,可能具有挑战性。在本文中,我们回顾了关于药物与抑郁症之间关联的文献。对于大多数药物,有病例报告或小型研究将该药物与抑郁症的发作联系起来,但要么缺乏更严格的前瞻性研究,要么发现该药物与抑郁症之间没有关联。然而,几种药物(例如巴比妥类药物、氨己烯酸、托吡酯、氟桂利嗪、皮质类固醇、甲氟喹、依非韦伦和α干扰素)确实似乎会在一些患者中导致抑郁症,在有抑郁症风险的患者中应谨慎使用。